ctrl K

Price Alert

Cytosorbents Corporation (CTSO)

NASDAQ: CTSO · Real-Time Price · USD

1.08

-0.02 (-1.82%)

At close: Aug 19, 2025, 3:59 PM

1.08

0.00%

After-hours: Aug 19, 2025, 04:04 PM EDT

Cytosorbents Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.28M	14.13M	22.14M	52.14M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	1.48M	1.48M	1.73M	1.94M
Other Long-Term Assets	22.64K	52.05K	1.73M	1.94M
Receivables	7.32M	6.06M	5.66M	4.52M
Inventory	2.73M	3.38M	3.46M	4.77M
Other Current Assets	8.27M	n/a	462.00	-85
Total Current Assets	21.6M	25.4M	33.76M	64.3M
Property-Plant & Equipment	20.51M	22.12M	23.35M	18.57M
Goodwill & Intangibles	3.75M	3.91M	4.39M	4.7M
Total Long-Term Assets	25.77M	27.56M	29.47M	25.22M
Total Assets	47.37M	52.96M	63.23M	89.52M
Account Payables	3.34M	3.8M	1.66M	2.81M
Deferred Revenue	419.33K	1.38M	1.52M	1.95M
Short-Term Debt	452.69K	2.5M	108.94K	570.57K
Other Current Liabilities	412.82K	991.54K	-108.49K	687.5K
Total Current Liabilities	9.82M	14.04M	9.71M	13.69M
Long-Term Debt	14M	2.54M	5M	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	26.44M	15.44M	18.14M	13.25M
Total Liabilities	36.26M	29.48M	27.86M	26.94M
Total Debt	26.89M	18.31M	18.25M	13.82M
Common Stock	54.83K	54.24K	43.63K	43.48K
Retained Earnings	-304.01M	-282.51M	-254M	-221.19M
Comprehensive Income	4.25M	529.32K	2.33M	525.59K
Shareholders Equity	11.11M	23.48M	35.38M	62.58M
Total Investments	1.48M	1.48M	1.73M	1.94M